Climb Bio Statistics

Total Valuation

Climb Bio has a market cap or net worth of $98.82 million. The enterprise value is -$119.05 million.

Market Cap	98.82M
Enterprise Value	-119.05M

Important Dates

The next estimated earnings date is Thursday, March 27, 2025, after market close.

Earnings Date	Mar 27, 2025
Ex-Dividend Date	n/a

Share Statistics

Climb Bio has 67.22 million shares outstanding. The number of shares has increased by 43.11% in one year.

Current Share Class	67.22M
Shares Outstanding	67.22M
Shares Change (YoY)	+43.11%
Shares Change (QoQ)	+120.81%
Owned by Insiders (%)	0.81%
Owned by Institutions (%)	40.53%
Float	30.25M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.45
P/TBV Ratio	0.45
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 57.73, with a Debt / Equity ratio of 0.00.

Current Ratio	57.73
Quick Ratio	56.78
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -42.08% and return on invested capital (ROIC) is -7.27%.

Return on Equity (ROE)	-42.08%
Return on Assets (ROA)	-7.15%
Return on Invested Capital (ROIC)	-7.27%
Return on Capital Employed (ROCE)	-8.75%
Revenue Per Employee	n/a
Profits Per Employee	-$6.28M
Employee Count	11
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -43.89% in the last 52 weeks. The beta is -0.23, so Climb Bio's price volatility has been lower than the market average.

Beta (5Y)	-0.23
52-Week Price Change	-43.89%
50-Day Moving Average	1.99
200-Day Moving Average	5.28
Relative Strength Index (RSI)	33.66
Average Volume (20 Days)	331,606

Short Selling Information

The latest short interest is 4.29 million, so 6.39% of the outstanding shares have been sold short.

Short Interest	4.29M
Short Previous Month	4.31M
Short % of Shares Out	6.39%
Short % of Float	14.20%
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-19.15M
Pretax Income	n/a
Net Income	-69.12M
EBITDA	n/a
EBIT	-19.15M
Earnings Per Share (EPS)	-$1.81

Full Income Statement

Balance Sheet

The company has $193.35 million in cash and $58,000 in debt, giving a net cash position of $217.87 million or $3.24 per share.

Cash & Cash Equivalents	193.35M
Total Debt	58,000
Net Cash	217.87M
Net Cash Per Share	$3.24
Equity (Book Value)	218.78M
Book Value Per Share	3.25
Working Capital	194.19M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-10.99M
Capital Expenditures	n/a
Free Cash Flow	-10.99M
FCF Per Share	-$0.16

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Climb Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-43.11%
Shareholder Yield	-43.11%
Earnings Yield	-69.95%
FCF Yield	-11.12%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2